NVM5
Device
NUVASIVE, INC.
Total Payments
$1.5M
Transactions
736
Doctors
431
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $64,121 | 64 | 48 |
| 2023 | $135,259 | 45 | 29 |
| 2022 | $78,486 | 34 | 24 |
| 2021 | $256,796 | 57 | 40 |
| 2020 | $288,149 | 89 | 68 |
| 2019 | $123,863 | 115 | 96 |
| 2018 | $228,556 | 207 | 128 |
| 2017 | $320,574 | 125 | 88 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $1.4M | 93 | 93.6% |
| Unspecified | $49,184 | 27 | 3.3% |
| Food and Beverage | $27,972 | 579 | 1.9% |
| Consulting Fee | $12,638 | 3 | 0.8% |
| Travel and Lodging | $6,042 | 32 | 0.4% |
| Entertainment | $10.00 | 2 | 0.0% |
Payments by Type
General
$1.4M
709 transactions
Research
$49,184
27 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NUVA.NV1401 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health | NUVASIVE, INC. | $35,638 | 0 |
| NUVA.NV1401 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health | NuVasive, Inc. | $11,301 | 3 |
| NUVA.NV1301 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health | NuVasive, Inc. | $2,000 | 0 |
| NUVA.AX1401 AttraX Putty vs. Autograft in eXtreme Lateral Interbody Fusion XLIF A Prospective Randomized Single-Center Evaluation of Radiographic and Clinical Outcomes | NuVasive, Inc. | $245.00 | 0 |
Top Doctors Receiving Payments for NVM5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Orthopaedic Surgery of the Spine | Vero Beach, FL | $581,058 | 28 |
| , M.D | Neurological Surgery | San Diego, CA | $408,735 | 15 |
| , MD | Orthopaedic Surgery of the Spine | Naperville, IL | $194,930 | 8 |
| , M.D | Orthopaedic Surgery | Miami Beach, FL | $129,240 | 20 |
| , MD | Neurological Surgery | Palo Alto, CA | $68,842 | 5 |
| Unknown | — | San Diego, CA | $42,709 | 21 |
| , M.D | Orthopaedic Surgery of the Spine | Chestnut Hill, MA | $13,128 | 6 |
| , MD | Orthopaedic Surgery of the Spine | New York, NY | $9,396 | 1 |
| , MD | Neurological Surgery | Boston, MA | $8,187 | 19 |
| , M.D | Neurological Surgery | Las Vegas, NV | $3,625 | 3 |
| , M.D | Orthopaedic Surgery of the Spine | Marietta, GA | $2,598 | 5 |
| , MD | Orthopaedic Surgery of the Spine | Salt Lake City, UT | $1,465 | 11 |
| , M.D | Orthopaedic Surgery of the Spine | Durango, CO | $1,246 | 9 |
| , M.D | Orthopaedic Surgery of the Spine | Austell, GA | $1,166 | 7 |
| , MD | Orthopaedic Surgery | Thousand Oaks, CA | $934.62 | 11 |
| , MD | Neurological Surgery | Jacksonville, FL | $707.28 | 4 |
| , M.D | Orthopaedic Surgery | Morris, IL | $583.33 | 2 |
| , MD | Orthopaedic Surgery | Kirkland, WA | $522.56 | 2 |
| , MD | Neurological Surgery | San Jose, CA | $516.30 | 2 |
| , M.D | Orthopaedic Surgery of the Spine | Fullerton, CA | $454.29 | 2 |
| , MD | Neurological Surgery | Ventura, CA | $421.49 | 13 |
| , DO | Orthopaedic Surgery | Phoenix, AZ | $380.01 | 4 |
| , MD | Neurological Surgery | Wilmington, NC | $300.00 | 1 |
| , M.D | Orthopaedic Surgery of the Spine | Meridian, ID | $277.44 | 5 |
| , MD | Gastroenterology | San Diego, CA | $271.80 | 1 |
Ad
Manufacturing Companies
- NuVasive, Inc. $1.1M
- NUVASIVE, INC. $314,099
- Globus Medical, Inc. $64,121
Product Information
- Type Device
- Total Payments $1.5M
- Total Doctors 431
- Transactions 736
About NVM5
NVM5 is a device associated with $1.5M in payments to 431 healthcare providers, recorded across 736 transactions in the CMS Open Payments database. The primary manufacturer is NUVASIVE, INC..
Payment data is available from 2017 to 2024. In 2024, $64,121 was paid across 64 transactions to 48 doctors.
The most common payment nature for NVM5 is "Royalty or License" ($1.4M, 93.6% of total).
NVM5 is associated with 4 research studies, including "NUVA.NV1401 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health" ($35,638).